Dolby Laboratories Stock Rises After Mixed Q3 Earnings Report
On July 31, Dolby Laboratories (NYSE: DLB) saw its stock rise by over 11% after reporting mixed financial results for fiscal Q3 2026. The company beat earnings estimates with non-GAAP EPS of $0.69 but missed revenue expectations at $305 million versus the forecasted $312 million. Year-over-year sales declined only slightly, by 3.5%, and Dolby's CEO expressed confidence in continued momentum across key growth areas. Looking ahead, Dolby expects Q4 to show strong sequential growth with projected revenues between $362 million and $392 million — a potential increase of up to 19%. The company also provided full-year guidance for at least $1.4 billion in revenue and GAAP earnings per share ranging from $2.62 to $2.77. Despite the positive stock reaction, analysts remain cautious about Dolby's valuation given its modest growth outlook.
Tickers: $DLB